Identification of Critical Residues in Novel Drug Metabolizing Mutants of Cytochrome P450 BM3 Using Random Mutagenesis
- 18 January 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (3) , 455-461
Abstract
Previously, we've described a site-directed triple mutant of cytochrome P450 BM3 (BM3) that is able to convert various drugs (van Vugt-Lussenburg, B. M. A., et al. Biochem. Biophys. Res. Commun. 2006, 346, 810−818). In the present study, random mutagenesis was used to improve the activity of this mutant. With three generations of error-prone PCR, mutants were obtained with 200-fold increased turnover toward drug substrates dextromethorphan and 3,4-methylenedioxymethylamphetamine. The initial activities of these mutants were up to 90-fold higher than that of human P450 2D6. These highly active drug metabolizing enzymes have great potential for biotechnology. Using sequencing analysis, the mutations responsible for the increase in activity were determined. The mutations that had the greatest effects on the activity were F81I, E267V, and particularly L86I, which is not located in the active site. Computer modeling studies were used to rationalize the effects of the mutations. This study shows that random mutagenesis can be used to identify novel critical residues, and to increase our insight into P450s.Keywords
This publication has 19 references indexed in Scilit:
- Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalystsBiochemical and Biophysical Research Communications, 2005
- Microbial P450 enzymes in biotechnologyApplied Microbiology and Biotechnology, 2004
- Biotransformations using prokaryotic P450 monooxygenasesCurrent Opinion in Biotechnology, 2002
- The production of fine chemicals by biotransformationsCurrent Opinion in Biotechnology, 2002
- Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylaseNature Biotechnology, 2002
- P450 BM3: the very model of a modern flavocytochromeTrends in Biochemical Sciences, 2002
- Cytochrome p450 enzymes in the generation of commercial productsNature Reviews Drug Discovery, 2002
- Pivotal Role of Water in the Mechanism of P450BM-3Biochemistry, 2001
- Roles of key active-site residues in flavocytochrome P450 BM3Biochemical Journal, 1999
- Structure of a cytochrome P450–redox partner electron-transfer complexProceedings of the National Academy of Sciences, 1999